EnCap Flatrock Midstream Fund VI, L.P. has submitted a new offering to the SEC, which could signal a significant step in its capital-raising efforts. This filing is particularly important as it comes at a time when the venture capital sector is witnessing increased activity and interest from investors.
Background
EnCap Flatrock Midstream Fund VI, L.P. is a limited partnership based in San Antonio, Texas. The company is incorporated in Delaware and focuses on pooled investment funds, specifically in the venture capital sector. The recent filing, dated October 29, 2026, is categorized under SEC regulations, indicating its compliance with the necessary legal frameworks. The firm has not disclosed its revenue range in the filing.
What the Filing Says
The SEC filing indicates that the offering is being made under Rule 506(b), which provides a safe harbor for private offerings. The document states, "Investment Company Act Section 3(c)" and includes several exemptions under federal regulations. The total offering amount is marked as indefinite, with no amounts sold yet, and it is noted that the first sale of securities is yet to occur.
Impact
This offering may affect various stakeholders, including potential investors looking for opportunities in the midstream sector. The filing indicates that there are no non-accredited investors involved at this stage, which typically suggests a focus on high-net-worth individuals or institutional investors. The absence of a minimum investment requirement may also attract a broader range of investors.
What's Next
The filing does not specify what happens next. However, the firm may proceed with marketing the offering to potential investors as it seeks to raise capital for its venture capital activities.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










